好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2016 Annual Meeting | Autoimmune Neurology I

Saturday 04/16/16
01:00 PM - 03:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Maarten J. Titulaer, MD, PhD
Participants should be able to understand the autoantibody nomenclature; recognize autoimmune neurologic disorders; know the neurologic and cancer associations of the autoantibodies; know the pitfalls in antibody testing; know the appropriate oncological evaluations for paraneoplastic neurologic disorders; and know some treatment regimens for autoimmune neurologic disorders.
2.00 CME credits
Trainee, General Neurologist, Specialist Neurologist
Case-based, Didactic, Audience Participation
Event Timeline
01:00 PM - 01:20 PM Intro - Overview of Autoimmune Neurology
Maarten J. Titulaer, MD, PhD
01:20 PM - 01:40 PM Classical Paraneoplastic Neurological Disorders
Andrew McKeon, MD
01:40 PM - 01:45 PM Questions and Answers
Andrew McKeon, MD
01:45 PM - 02:10 PM Autoimmune Disorders of the Peripheral Nervous System
Christopher J. Klein, MD, FAAN
02:10 PM - 02:15 PM Questions and Answers
Christopher J. Klein, MD, FAAN
02:15 PM - 02:35 PM Autoimmune Encephalitis - The Cell Surface and Synaptic Antibodies
Josep O. Dalmau, MD, PhD, FAAN
02:35 PM - 02:40 PM Questions and Answers
Josep O. Dalmau, MD, PhD, FAAN
02:40 PM - 03:00 PM Clinical Pearls
Josep O. Dalmau, MD, PhD, FAAN, Christopher J. Klein, MD, FAAN, Andrew McKeon, MD, Maarten J. Titulaer, MD, PhD
Faculty Disclosures
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Eric Lancaster, MD, PhD Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program.
Maarten J. Titulaer, MD, PhD The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received publishing royalties from a publication relating to health care.
Josep O. Dalmau, MD, PhD, FAAN Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Andrew McKeon, MD The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.